On February 16, Kang Keren, senior vice president of Guangzhou Wondfo Biotech Co.Ltd(300482) , said that in view of the epidemic situation in Hong Kong, Guangzhou Wondfo Biotech Co.Ltd(300482) ‘s “anti epidemic vanguard” had been prepared and was preparing to go to the front line to protect the supply with science and technology and fully support Hong Kong’s anti epidemic.
As one of the leading enterprises in China’s POCT, Guangzhou Wondfo Biotech Co.Ltd(300482) ‘s New Coronavirus (2019-nCoV) antibody test kit (colloidal gold method) and New Coronavirus (2019-nCoV) antigen detection kit (colloidal gold method) are the first batch of COVID-19 fast detection products approved by China. Covid-19 antigen rapid detection is simple and independent of equipment. It can realize on-site detection and give results in 15-20 minutes.
At present, Guangzhou Wondfo Biotech Co.Ltd(300482) has developed a variety of fast, accurate, simple and easy-to-use detection products, which can provide covid-19 full scene products and solutions in the trinity of “nucleic acid PCR + antigen + antibody”, and can meet different application scenarios of covid-19 virus on-site rapid detection.
Kang Keren said that since the outbreak, Guangzhou Wondfo Biotech Co.Ltd(300482) has given full play to its own advantages, taken multiple measures to allocate resources, made every effort to improve production capacity, went all out to provide support for epidemic prevention and control, and repeatedly supported the global demand for anti epidemic. “In view of the epidemic situation in Hong Kong, we will do our best to give full support to Hong Kong and stand ready to support the forefront of the fight against the epidemic.”
At present, Guangzhou Wondfo Biotech Co.Ltd(300482) ‘s “anti epidemic vanguard” has been prepared and is ready to go to the front line to provide support for the anti epidemic. It is reported that the “anti epidemic vanguard” established by Guangzhou Wondfo Biotech Co.Ltd(300482) has participated in the anti epidemic for many times, provided product use training and testing support to relevant units, and can go deep into the closed and sealed management area, transport covid-19 antigen detection reagents, carry out product operation training, and provide on-site technical support for testing.
In addition, Guangzhou Wondfo Biotech Co.Ltd(300482) is assisting the second people’s Hospital of Guangdong Province to carry out the pilot work of rapid detection and application of covid-19 virus antigen. Guangzhou Wondfo Biotech Co.Ltd(300482) launched the digital intelligent prevention and control scheme for the detection of covid-19 antigen, which is currently collected, inspected and reported. It has been applied in the closed and sealed management areas, international shipping and import prevention and control outside China. It is reported that the company’s rapid antigen detection has played an important role in emergency first aid for many times. The relevant mature experience can be applied to the anti epidemic in Hong Kong to provide support for improving the efficiency of anti epidemic.
